Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 2,032 shares at $8.53 ($17K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Scheduled sale ($17k) by CFO and CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |